BiotechTube
Home/Bright Minds Biosciences/Mark G. Boshar
MG

Mark G. Boshar

Chief Financial Officer

Bright Minds Biosciences

Therapeutic Areas

PsychiatryNeurologyNeuroscience

Bright Minds Biosciences Pipeline

DrugIndicationPhase
BMB-101Treatment-Resistant Depression (TRD)Phase 2
BMB-202Focal Onset Seizures / EpilepsyPhase 1/2

Leadership Team at Bright Minds Biosciences

IM
Ian McDonald
Chief Executive Officer & Director
AK
Alan Kozikowski
Chief Scientific Officer & Co-Founder
JG
Jeremy Goodwin
Chief Operating Officer
View full Bright Minds Biosciences profile